JP2016014660A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016014660A5 JP2016014660A5 JP2015116494A JP2015116494A JP2016014660A5 JP 2016014660 A5 JP2016014660 A5 JP 2016014660A5 JP 2015116494 A JP2015116494 A JP 2015116494A JP 2015116494 A JP2015116494 A JP 2015116494A JP 2016014660 A5 JP2016014660 A5 JP 2016014660A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- detecting
- inflammatory
- inflammatory biomarkers
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17210109P | 2009-04-23 | 2009-04-23 | |
| US61/172,101 | 2009-04-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507451A Division JP2012524910A (ja) | 2009-04-23 | 2010-04-23 | 免疫調節物質の同定方法及びシステム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016014660A JP2016014660A (ja) | 2016-01-28 |
| JP2016014660A5 true JP2016014660A5 (https=) | 2016-04-28 |
Family
ID=42993293
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507451A Pending JP2012524910A (ja) | 2009-04-23 | 2010-04-23 | 免疫調節物質の同定方法及びシステム |
| JP2015116494A Pending JP2016014660A (ja) | 2009-04-23 | 2015-06-09 | 免疫調節物質の同定方法及びシステム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507451A Pending JP2012524910A (ja) | 2009-04-23 | 2010-04-23 | 免疫調節物質の同定方法及びシステム |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20100275282A1 (https=) |
| EP (1) | EP2422200A4 (https=) |
| JP (2) | JP2012524910A (https=) |
| WO (1) | WO2010124256A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| JP2011503104A (ja) | 2007-11-09 | 2011-01-27 | カリフォルニア インスティテュート オブ テクノロジー | 免疫調節化合物ならびに関連組成物および方法 |
| JP6027961B2 (ja) * | 2010-04-07 | 2016-11-16 | シェン, ユエSHEN, Yue | 粘膜へ化合物を送るための媒体、それに関連する組成物、方法、及びシステム |
| JP2013530949A (ja) | 2010-05-20 | 2013-08-01 | エル ラウンド ジューン | 抗原特異的Ｔｒｅｇ並びに関連する組成物、方法及びシステム |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| US20130064859A1 (en) * | 2011-01-28 | 2013-03-14 | Sarkis K. Mazmanian | Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease |
| US9539281B2 (en) | 2011-07-12 | 2017-01-10 | The Brigham And Women's Hospital, Inc. | Lipid-containing PSA compositions, methods of isolation and methods of use thereof |
| WO2013019896A1 (en) * | 2011-08-01 | 2013-02-07 | Symbiotix Biotherapies, Inc. | Platform for identifying and/or characterizing immunomodulatory agents |
| US9057070B2 (en) | 2011-10-03 | 2015-06-16 | California Institute Of Technology | Generation of Bacteriodes fragilis capsular polysaccharide A-only producing mutant strain |
| ES2993669T3 (en) | 2011-12-01 | 2025-01-03 | Univ Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| CA2911826C (en) | 2013-05-10 | 2022-08-23 | California Institute Of Technology | Probiotic prevention and treatment of colon cancer |
| WO2016201342A1 (en) | 2015-06-10 | 2016-12-15 | California Institute Of Technology | Sepsis treatment and related compositions methods and systems |
| JP6918365B2 (ja) | 2015-08-19 | 2021-08-11 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 脂質化ｐｓａ組成物および方法 |
| KR102569754B1 (ko) | 2015-09-10 | 2023-08-23 | 위니베르시트카솔리끄드루뱅 | 대사장애를 치료하기 위한 살균된 아커만시아의 용도 |
| US11491181B2 (en) | 2016-07-15 | 2022-11-08 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
| US10823699B2 (en) | 2016-07-29 | 2020-11-03 | Vital Biosciences, Inc. | Gel electrophoresis diagnostic kit and methods of using the same |
| WO2018119437A2 (en) | 2016-12-23 | 2018-06-28 | Confer Health, Inc. | Electrophoresis diagnostic methods and kits |
| JP6836756B2 (ja) * | 2017-09-21 | 2021-03-03 | 光博 岡野 | 口腔細菌叢中の構成叢比を予測する方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5679654A (en) * | 1994-09-02 | 1997-10-21 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
| US5700787A (en) * | 1994-09-02 | 1997-12-23 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
| US7083777B1 (en) * | 1999-04-02 | 2006-08-01 | The Brigham And Women's Hospital, Inc. | Immunomodulating polymers |
| SV2003000753A (es) * | 2000-12-05 | 2003-06-16 | Brigham & Womens Hospital | Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico |
| US7524509B2 (en) * | 2001-03-09 | 2009-04-28 | Id Biomedical Corporation Of Quebec | Proteosome-liposaccharide vaccine adjuvant |
| JP2003204796A (ja) * | 2001-11-08 | 2003-07-22 | Japan Science & Technology Corp | 非ヒト遺伝子改変動物およびその利用 |
| US7829289B2 (en) * | 2002-05-14 | 2010-11-09 | Institut National De La Sante Et De Recherche Medicale | T cell subpopulation regulating gut immunity |
| US20060160153A1 (en) * | 2002-12-03 | 2006-07-20 | Jean-Pierre Abastado | Method to measure a t cell response and its uses to qualify antigen-presenting cells |
| WO2004089407A2 (en) * | 2003-03-31 | 2004-10-21 | The Brigham And Women's Hospital, Inc. | Zwitterionic immunomodulators for the treatment of asthma and allergy |
| US20050048587A1 (en) * | 2003-07-17 | 2005-03-03 | Tolerrx, Inc. | Methods for identifying tolerance modulatory compounds and uses therefor |
| JPWO2005094571A1 (ja) * | 2004-03-31 | 2008-02-14 | 独立行政法人科学技術振興機構 | 遺伝子改変ヘテロ動物及び該動物を用いたエキソサイトシスの計測方法 |
| US8426146B2 (en) * | 2005-06-03 | 2013-04-23 | University of Pittsburgh—of the Commonwealth System of Higher Education | Multiparameteric method for assessing immune system status |
| JP2007119414A (ja) * | 2005-10-31 | 2007-05-17 | Univ Nagoya | Ｃｄ８＋ｃｄ１２２＋ｔ細胞の免疫抑制活性を増強させる免疫抑制剤 |
| US8206726B2 (en) * | 2006-02-06 | 2012-06-26 | The Brigham And Women's Hospital, Inc. | Zwitterionic polysaccharides for promotion of immune system maturation and health |
| WO2008150491A2 (en) * | 2007-05-31 | 2008-12-11 | Abbott Laboratories | BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNFα INHIBITORS IN AUTOIMMUNE DISORDERS |
-
2010
- 2010-04-23 US US12/766,787 patent/US20100275282A1/en not_active Abandoned
- 2010-04-23 JP JP2012507451A patent/JP2012524910A/ja active Pending
- 2010-04-23 WO PCT/US2010/032300 patent/WO2010124256A2/en not_active Ceased
- 2010-04-23 EP EP10767863A patent/EP2422200A4/en not_active Withdrawn
-
2015
- 2015-06-09 JP JP2015116494A patent/JP2016014660A/ja active Pending
-
2016
- 2016-01-29 US US15/011,151 patent/US20170003274A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016014660A5 (https=) | ||
| Valverde-Molina et al. | Microbiome and asthma: microbial dysbiosis and the origins, phenotypes, persistence, and severity of asthma | |
| Bertoletti et al. | SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic | |
| Hisamatsu et al. | Immune aspects of the pathogenesis of inflammatory bowel disease | |
| Maksimović et al. | Mycoplasma ovipneumoniae: a most variable pathogen | |
| JP2018508198A5 (https=) | ||
| Bayes et al. | T helper cell subsets specific for Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis | |
| JP2013504623A5 (https=) | ||
| Wang et al. | The regulatory T cells in anti-influenza antibody response post influenza vaccination | |
| Khalifa et al. | Bacillus amyloliquefaciens enriched camel milk attenuated colitis symptoms in mice model | |
| Authier et al. | Oral administration of Lactobacillus helveticus LA401 and Lactobacillus gasseri LA806 combination attenuates oesophageal and gastrointestinal candidiasis and consequent gut inflammation in mice | |
| Foey et al. | Lacticaseibacillus casei strain shirota modulates macrophage-intestinal epithelial cell co-culture barrier integrity, bacterial sensing and inflammatory cytokines | |
| Ries et al. | Isolation and cultivation of a new isolate of BTV-25 and presumptive evidence for a potential persistent infection in healthy goats | |
| Niculita-Hirzel et al. | Season, vegetation proximity and building age shape the indoor fungal communities’ composition at city-scale | |
| Chepkwony et al. | Efficacy of heterologous prime-boost vaccination with H3N2 influenza viruses in pre-immune individuals: studies in the pig model | |
| Ahn et al. | The effect of probiotics on intestinal tight junction protein expression in animal models: a meta-analysis | |
| Yi et al. | Segmented filamentous bacteria induce divergent populations of antigen-specific CD4 T cells in the small intestine | |
| Liu et al. | Probiotic Lactobacillus johnsonii reduces intestinal inflammation and rebalances splenic Treg/Th17 responses in dextran sulfate sodium-induced colitis | |
| Bacalhau et al. | Laboratory tools to predict CFTR modulator therapy effectiveness and to monitor disease severity in cystic fibrosis | |
| Gozalbo-Rovira et al. | Microbiota depletion promotes human rotavirus replication in an adult mouse model | |
| Wang et al. | Bacterial and fungal aerosols in poultry houses: PM2. 5 metagenomics via single-molecule real-time sequencing | |
| O’Dowd et al. | Distinct miRNA profile of cellular and extracellular vesicles released from chicken tracheal cells following avian influenza virus infection | |
| Li et al. | Diagnosis of a Rabbit Hemorrhagic Disease Virus 2 (RHDV2) and the humoral immune protection effect of VP60 vaccine | |
| Cruz Cisneros et al. | Host genetic variation impacts SARS-CoV-2 vaccination response in the diversity outbred mouse population | |
| Rattan et al. | Development of a mouse model to explore CD4 T cell specificity, phenotype, and recruitment to the lung after influenza b infection |